Search results
Author(s):
James Udelson
Added:
2 months ago
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the…
View more
John J Atherton
Research Area(s) / Expertise:
Author
Expertise
Author(s):
William T Abraham
,
Hanad Bashir
Added:
1 year ago
AHA 23 — Dr Hanad Bashir, CardioNerds ambassador, interviews Prof William T Abraham (The Ohio State University, US) on the findings of a clinical evaluation of the Cordio app in adult patients with acute decompensated heart failure.The Cordio "HearO" app (Cordio Medical) uses patient speech sampled via mobile phone to sense fluid accumulation related to chronic heart failure, and provides alerts…
View more
Author(s):
Jesús Álvarez-García
Added:
1 year ago
ESC 23 — Dr Jesus Alvarez-Garcia (Ramon and Cajal University Hospital, ES) considers the use of ReDS technology in patients with acute heart failure (ReDS-SAFE HF) (NCT04305717) in this short interview.
The ReDS-SAFE HF study (Icahn School of Medicine at Mount Sinai) aimed to test the remote dielectric sensing (ReDS) system, a novel electromagnetic technology that can noninvasively quantify…
View more
Added:
2 months ago
Source:
THT
THT conference has released its four late-breaking trial sessions for 2025.The fourth annual Technology and Heart Failure Therapeutics conference is set to take place from the 11th to 13th February at Omni Boston Hotel at the Seaport in Boston. Access the full programme here.Late Breaking Clinical Science Session ITuesday 11th February, 09:30 – 10:45am ESTRobotic Surgical Technique for Performing…
View more
Author(s):
Harriette Van Spall
,
Mark Petrie
Added:
11 months ago
HFA 2024 — Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Mark Petrie (University of Glasgow, UK) for an insightful wrap up of the novel data presented at 2024's Heart Failure Congress.00:24 - STEP HFpEF Programme: Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF & Semaglutide therapy and diuretic use in obesity-related HFpEF02:20 - EMPACT-MI: The effect of…
View more
HFA 24: Late-Breaking Science Video Collection
Video Series
Author(s):
Antonio Luca Maria Parlati
,
Cristina Madaudo
,
Vincenzo Nuzzi
,
et al
Added:
2 months ago
‘Residual Congestion’ in HF
Author(s):
Aleksandra Gasecka
,
Aleksander Siniarski
Added:
1 month ago
Article
Author(s):
Rafael de la Espriella
,
Gonzalo Núñez-Marín
,
Pau Codina
,
et al
Added:
1 year ago